 |
 |
      |
|
|
|
|
Oncologic Emergencies: Nephropathy and Tumor Lysis Syndrome
- Module 1: Oncologic Emergencies: Nephropathy and Tumor Lysis Syndrome
Scott Howard, MD, MSc
Jorge E. Cortes, MD
- Module 2: Case Studies in Oncologic Emergencies: Tumor Lysis Syndrome in Adults with Leukemia
Scott Howard, MD, MSc
Jorge E. Cortes, MD
- Module 3: Case Studies in Oncologic Emergencies: Tumor Lysis Syndrome and Hemolysis in Acute Lymphoblastic Leukemia
Scott Howard, MD, MSc
Jorge E. Cortes, MD
Practice-Changing Highlights From San Francisco 2008:
Hematology Treatment Updates
- Module I: Updates in Multiple Myeloma
Henry C. Fung, MD, FRCPE
- Module II: Updates in Coagulopathy
Jean-Bernard Durand, MD
- Module III: Updates in Leukemia and Lymphoma
Gautam Borthakur, MD
Healthcare Provider Conference 2008:
Collaboration for Advancing the Quality of Community
Cancer Care
- Module I: New Drugs & Indications: Focus on Hematologic Disorders and Solid Tumors (Module review time- 34:29)
Jill Kolesar, PharmD, BCPS, FCCP, RPh
Modules I through V must all be taken to receive credit.
- Module II: Reimbursement in the Oncology Practice: 2008 Update and Audience Case Challenges (Module review time- 33:10)
Karen Pilley, CPC, CCS-P
Modules I through V must all be taken to receive credit.
- Module III: Breast Cancer: Implementing Advances into Practice (Module review time- 38:26)
Mary Ann K. Allison, MD, FACP
Modules I through V must all be taken to receive credit.
- Module IV: Bone Marrow Transplantation: The Basics (Module review time- 35:22)
Roy A. Beveridge, MD
Modules I through V must all be taken to receive credit.
- Module V: Integrative Medicine and Community Cancer Care: Putting it into Practice (Module review time- 24:49)
Sami Diab, MD
Joan Engebretson, DrPH, AHN-BC, RN
Michael Forsyth, RPh, MBA
Moshe Frenkel, MD
Patty Gerken, ANP-BC, AOCN
Modules I through V must all be taken to receive credit.
Treatment-Related Highlights from Chicago 2008
August 2008
Session I
- Module I: Hematologic Malignancy Updates
Nicholas DiBella, MD
- Module II: Updates in Genitourinary Cancers
William Berry, MD
Session II
- Module III: Lung Cancer Updates
Robert Jotte, MD, PhD
- Module IV: Updates on Gastrointestinal Cancer
Thomas H. Cartwright, MD
Session III
- Module V: Breast Cancer Updates
Michael Kolodziej, MD
- Module VI: Biomarkers and Individualization of Treatment in Cancer Patients
Howard L. McLeod, PharmD
Infections in Cancer Patients:
Prevention and Management in the Community Care Setting
April 2008
- Session I: Practical Management of Febrile Neutropenia
Amar Safdar, MD, Estil Vance, MD
- Session II: Emerging Bacterial/MRSA Infections
Roy F. Chemaly, MD, MPH, FACP, FIDSA, Estil Vance, MD
- Session III: Practical Management & Prevention of Infections in Cancer Patients
Amar Safdar, MD, Estil Vance, MD
Lung Cancer Care in 2007:
A Multidisciplinary Approach
October 2007
- Module I: Overview of Chemotherapy in Adjuvant NSCLC
Dr. Alan Sandler, Dr. Kartik Konduri
- Module II: Update on the Current State of CT Screening
Dr. James Mulshine
- Module III: Practical Applications of Combined Modalities for the Treatment of Early-Stage NSCLC
Dr. Gregory Kalemkerian
- Module IV: Role and Sequence of Combined Modality Treatment in NSCLC
Dr. Laurie Gaspar
- Module V: Controversies in the Surgical Management of Early-
Stage NSCLC
Dr. Louis Jacques
- Module VI: Early Stage Lung Cancer: Presentation of Challenging Cases and Panel Discussion
Minneapolis, MN; October 6, 2007
- Module VII: Early Stage Lung Cancer: Presentation of Challenging Cases and Panel Discussion
Houston, TX; October 20, 2007
- Module VIII: The Biology of Antiangiogenic Agents and Their Use in Metastatic Lung Cancer
Dr. Patrick J. Flynn
- Module IX: First-line Therapy: Beyond Cytotoxic Chemotherapy With the Introduction of Targeted Agents
Dr. H. Jack West
- Module X: Predictive Indicators for Response in NSCLC
Dr. Craig H. Reynolds
- Module XI: Novel Strategies for Treating Second and Refractory Lung Cancer
Dr. Suresh Ramalingam
- Module XII: Treatment of Metastatic NSCLC: Presentation of Challenging Cases and Panel Discussion
Minneapolis, MN; October 6, 2007
- Module XIII: Treatment of Metastatic NSCLC: Presentation of Challenging Cases and Panel Discussion
Houston, TX; October 20, 2007
Practice-Changing Highlights from Chicago 2007
July 2007
- Module I: Breast Cancer Adjuvant/Neoadjuvant Therapy
- Module II: Genitourinary Cancers
- Module III: Supportive Care and Other Advances
- Module IV: Advances in Treatment of Hematologic Malignancies
- Module V: Gastrointestinal Cancers
- Module VI: Lung Cancer
Oncology Nursing, Midlevel Practitioner and Pharmacy Conference 2006: Collaboration for Advancing the Quality of Community Cancer Care
December 2006
- Module I: Novel Therapies in the Treatment of Multiple Myeloma, Lymphoma and Myelodysplastic Syndromes
- Module II: From the Bench to the Bedside: New Drug Highlights
- Module III: At the Crossroads: End of Life Issues in
Cancer Care
- Module IV: Facilitating Communication on Sensitive Issues in Cancer Care
- Module V: On the Horizon of Genetic Research: From Investigator to Reporter to the Public
- Module VI: Women and Cancer: A Focus on Cervical and Ovarian Cancers
- Module VII: Breast Cancer: Application of the Latest Data and Its Implications
- Module VIII: Cancer Comorbidities: Understanding and Managing Toxicity Risks and Late Effects of Treatment
- Module IX: Supportive Care Therapies and Management
- Module X: Optimizing Oral Therapies: What We Need to Know About Delivery and Compliance
- Module XI: Delivering Cancer Care in 2006: Commanding Reimbursement and Regulatory Issues
|
|
|
|
|
 |
 |
|
|
|
|
|
|